Answer
When specified in the indication, tumour PD-L1 expression used to select patients for nivolumab (OPDIVO) should be confirmed by a validated test.
Sources for this answer
- OPDIVO 10 mg/mL concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.2 Posology and method of administration · Version 67Document updated
Sources checked